Neovascular age-related macular degeneration Clinical Trials

Delta Trials indexes 185 clinical trials for Neovascular age-related macular degeneration in its publicly accessible dataset. Of these, 18 enrolling participants at this time and 115 trials have reached completion. This research takes place spanning 1,110 research sites around the world. An additional 52 trials are in preparatory or other active non-recruiting stages. Since 2020, 15 trials were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.